Viral exanthems

Current Opinion in Infectious Diseases

Volumn 28, Issue 2, 2015, Pages 139-150

  Keighley, Caitlin L ^a,b   Saunderson, Rebecca B ^a   Kok, Jen ^a,b,c   Dwyer, Dominic E ^a,b,c  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Sydney   (Australia)

Author keywords

Exanthem; Gianotti Crosti syndrome; Rash; Viral infection; Virus

Indexed keywords

INFLUENZA VACCINE; MEASLES VACCINE; RUBELLA VACCINE;

ALPHA VIRUS; ALPHAVIRUS INFECTION; ARBOVIRUS; BARMAH FOREST VIRUS; BIOLOGICAL WARFARE; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CLIMATE CHANGE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENGUE; DENGUE VIRUS; EBOLA VIRUS; ENTEROVIRUS INFECTION; EPIDEMIC; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; ERYTHEMA INFECTIOSUM; EXANTHEMA SUBITUM; FILOVIRUS; FILOVIRUS INFECTION; FLAVIVIRUS; FLAVIVIRUS INFECTION; GREENHOUSE EFFECT; HAND FOOT AND MOUTH DISEASE; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX VIRUS 1; HERPES ZOSTER; HERPESVIRIDAE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; JAPANESE ENCEPHALITIS; MANAGED CARE; MEASLES; MEASLES VIRUS; MURRAY VALLEY ENCEPHALITIS; PAPULAR ACRODERMATITIS; PAPULAR PURPURIC GLOVES AND SOCKS SYNDROME; RASH; REVIEW; ROSS RIVER ALPHA VIRUS; RUBELLA; SKIN BIOPSY; SMALLPOX; TRAVEL; TROPICAL DISEASE; VACCINATION; VARICELLA ZOSTER VIRUS; VESICULAR RASH; VIRAL EXANTHEM; VIRAL SKIN DISEASE; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; ZIKA VIRUS; DIAGNOSTIC TEST; EXANTHEMA; HEALTH; ISOLATION AND PURIFICATION; PROCEDURES; VIROLOGY; VIRUS; VIRUS DISEASES;

DIAGNOSTIC TESTS, ROUTINE; EXANTHEMA; GLOBAL HEALTH; HUMANS; VIRUS DISEASES; VIRUSES;

EID: 84926371021     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000145     Document Type: Review

References (86)

1. Drago F, Paolino S, Rebora A, et al. The challenge of diagnosing atypical exanthems: A clinico-laboratory study. J Am Acad Dermatol 2012; 67: 1282-1288.
2. Mage V, Lipsker D, Barbarot S, et al. Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults. J Am Acad Dermatol 2014; 71:62-69.
3. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15:485-505.
4. Katta R. Parvovirus B19: A review. Dermatol Clin 2002; 20:333-342.
5. Hashimoto H, Yuno T. Parvovirus B19-associated purpuric-petechial eruption. J Clin Virol 2011; 52:269-271.
6. Yermalovich MA, Hübschen JM, Semeiko GV, et al. Human parvovirus B19 surveillance in patients with rash and fever from Belarus. J Med Virol 2012; 84:973-978.
7. Di Lernia V, Mansouri Y. Epstein-Barr virus and skin manifestations in childhood. Int J Dermatol 2013; 52:1177-1184.
8. World Health Organisation. Handbook Integrated Management of Childhood Illness. 2005. http://whqlibdoc.who.int/publications/2005/9241546441.pdf. [Accessed 3 October 2014]
9. Tanaka-Taya K, Sashihara J, Kurahashi H, et al. Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol 2004; 73:465-473.
10. Blauvelt A. Skin diseases associated with human herpesvirus 6, 7, and 8 infection. J Investig Dermatol Symp Proc 2001; 6:197-202.
11. Outhred AC, Kok J, Dwyer DE. Viral arthritides. Expert Rev Anti Infect Ther 2011; 9:545-554.
12. Messedi E, Fki-Berrajah L, Gargouri S, et al. Clinical epidemiological and molecular aspects of rubella outbreak with high number of neurological cases, Tunisia 2011-2012. J Clin Virol 2014; 61:248-254.
13. Harada T, Ohtaki E, Tobaru T, et al. Rubella-associated perimyocarditis: A case report. Angiology 2002; 53:727-732.
14. Kö nig AL, Schabel A, Sugg U, et al. Autoimmune hemolytic anemia caused by IgG lambda-monotypic cold agglutinins of anti-Pr specificity after rubella infection. Transfusion 2001; 41:488-492.
15. Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 2014; 370:818-828.
16. Paller AS, Mancini A. Hurwitz Clinical Pediatric Dermatology. 4th ed. Philadelphia: Saunders; 2011; Expert Consult.
17. Zhou H-T, Guo Y.-H, Tang P, et al. No exanthema is related with death and illness severity in acute enterovirus infection. Int J Infect Dis 2014; 28:123-125.
18. Feder HM Jr, Bennett N, Modlin JF. Atypical hand, foot, and mouth disease: A vesiculobullous eruption caused by Coxsackie virus A6. Lancet Infect Dis 2014; 14:83-86.
19. Mathes EF, Oza V, Frieden IJ, et al. Eczema coxsackium and unusual cutaneous findings in an enterovirus outbreak. Pediatrics 2013; 132:e149-e157.
20. Nguyen NTB, Pham HV, Hoang CQ, et al. Epidemiological and clinical characteristics of children who died from hand, foot and mouth disease in Vietnam, 2011. BMC Infect Dis 2014; 14:341.
21. Horsley E, Just E, Torres C, et al. Enterovirus 71 outbreak in Northern Sydney 2013: Case series and initial response. J Paediatr Child Health 2014; 50:525-530.
22. Biao D, Ying Z, Huaping X, et al. Circulation of coxsackievirus A6 in hand-footmouth disease in Guangzhou, 2010-2012. Virol J 2014; 11:157.
23. Hongyan G, Chengjie M, Qiaozhi Y, et al. Hand, foot and mouth disease caused by coxsackievirus A6, Beijing, 2013. Pediatr Infect Dis J 2014; 33:1302-1303.
24. Puenpa J, Mauleekoonphairoj J, Linsuwanon P, et al. Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. PLoS One 2014; 9:e98888.
25. Hubiche T, Schuffenecker I, Boralevi F, et al. Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema. Pediatr Infect Dis J 2014; 33:e92-e98.
26. Puenpa J, Chieochansin T, Linsuwanon P, et al. Hand, foot, and mouth disease caused by coxsackievirus A6, Thailand, 2012. Emerg Infect Dis 2013; 19:641-643.
27. MontesM, Artieda J, Piñ eiro LD, et al. Hand, foot, and mouth disease outbreak and coxsackievirus A6, northern Spain, 2011. Emerg Infect Dis 2013; 19:676-678.
28. Huang W-C, Huang L-M, Lu C-Y, et al. Atypical hand-foot-mouth disease in children: A hospital-based prospective cohort study. Virol J 2013; 10:209.
29. Lu Q-B, Zhang X-A, Wo Y, et al. Circulation of coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011. PLoS One 2012; 7:e52073.
30. Prevention ECFD, Team CEHCUEE. Continued seasonal circulation of enterovirus D68 in the Netherlands, 2011-2014. European Centre for Disease Prevention and Control (ECDC). 2014, 19.
31. Migué lez A, Dueñ as J, Hervás D, et al. Flagellate erythema in parvovirus B19 infection. Int J Dermatol 2014; 53:3583-3585.
32. Iwasaki E, Takita M, Kishino R, et al. AdultGianotti-Crosti syndrome caused by hepatitis B. Nihon Shokakibyo Gakkai Zasshi 2013; 110:1657-1662.
33. Stojkovic-Filipovic J, Skiljevic D, Brasanac D, Medenica L. Gianotti-Crosti syndrome associated with Ebstein-Barr virus and Parvovirus B-19 co-infection in a male adult: Case report and review of the literature. G Ital Dermatol Venereol 2014; http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?db from=pubmed&id=25034095&retmode=ref&cmd=prlinks.
34. Biesbroeck L, Sidbury R. Viral exanthems: An update. Dermatol Ther 2013; 26:433-438.
35. Kappus MR, Sterling RK. Extrahepatic manifestations of acute hepatitis B virus infection. Gastroenterol Hepatol 2013; 9:123-126.
36. Ishida T, Kano Y, Mizukawa Y, Shiohara T. The dynamics of herpesvirus reactivations during and after severe drug eruptions: Their relation to the clinical phenotype and therapeutic outcome. Allergy 2014; 69:798-805.
37. Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev 2013; 26:728-743.
38. Caseris M, Houhou N, Longuet P, et al. French 2010-2011 measles outbreak in adults: Report from a Parisian teaching hospital. Clin Microbiol Infect 2014; 20:O242-O244.
39. Hocqueloux L, Guinard J, Buret J, et al. Do penicillins really increase the frequency of a rash when given during Epstein-Barr virus primary infection? Clin Infect Dis 2013; 57:1661-1662.
40. Chovel-Sella A, Ben Tov A, Lahav E, et al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics 2013; 131:e1424-1427.
41. de Moraes JC, Toscano CM, de Barros ENC, et al. Etiologies of rash and fever illnesses in Campinas. Brazil J Iinfect Dis 2011; 204 (Suppl 2):S627-S636.
42. Tabak F, Murtezaoglu A, Tabak O, et al. Clinical features and etiology of adult patients with fever and rash. Ann Dermatol 2012; 24:420-425.
43. Sparrer KMJ, Krebs S, Jager G, et al. Complete genome sequence of a wildtype measles virus isolated during the spring 2013 epidemic in Germany. Genome Announcements 2014; 2:e00157-e214.
44. Weston KM, Dwyer DE, Ratnamohan M, et al. Nosocomial and community transmission of measles virus genotype D8 imported by a returning traveller from Nepal. Commun Dis Intell Q Rep 2006; 30:358-365.
45. Weekly Epidemiological Record [Internet]. 2011. http://www.who.int/wer/2011/wer8649.pdf?ua=1. [Accessed 8 November 2014]
46. CDC-Measles: Cases and outbreaks [Internet]. 2014. http://www.cdc.com [Accessed 3 October 2014].
47. Ujiie M, Nabae K, Shobayashi T. Rubella outbreak in Japan. Lancet 2014; 383:1460-1461.
48. Singh MP, Kumar A, Gautam N, et al. Rubella outbreak in the union territory of Chandigarh North India. J Med Virol 2014; 87:344-349.
49. Xu H, Gao X, Bo F, et al. A rubella outbreak investigation and BRD-II strain rubella vaccine effectiveness study, Harbin city, Heilongjiang province, China, 2010-2011. Vaccine 2013; 32:85-89.
50. Koul PA, Khan UH, Shah TH, et al. Skin rash and subconjunctival haemorrhage in an adult with pandemic H1N1 influenza. Case Reports 2013; 1:bcr2013010216-6.
51. Rosenberg M, Tram C, Kuper A, Daneman N. Rash associated with pandemic (H1N1) influenza. CMAJ 2010; 182:E146.
52. Wiwanitkit S,Wiwanitkit V. Incidence of skin rash in the new H7N9 influenza. Indian J Dermatol 2014; 59:529.
53. Kaley J, Pellowski DM, Cheung WL, et al. The spectrum of histopathologic findings in cutaneous eruptions associated with influenza A (H1N1) infection. J Cutan Pathol 2013; 40:226-229.
54. Zenner D, Nacul L. Predictive power of Koplik's spots for the diagnosis of measles. J Infect Dev Ctries 2012; 6:271-275.
55. Powers AM, Logue CH. Changing patterns of chikungunya virus: Re-emergence of a zoonotic arbovirus. J Gen Virol 2007; 88 (Pt 9):2363-2377.
56. Caglioti C, Lalle E, Castilletti C, et al. Chikungunya virus infection: An overview. New Microbiol 2013; 36:211-227.
57. Mowatt L, Jackson ST. Chikungunya in the Caribbean: An epidemic in the making. Infect Dis Ther 2014; 3:63-68.
58. Chusri S, Siripaitoon P, Silpapojakul K, et al. Kinetics of Chikungunya infections during an outbreak in southern Thailand, 2008-2009. Am J Trop Med Hyg 2014; 90:410-417.
59. Robin S, Ramful D, Zettor J, et al. Severe bullous skin lesions associated with Chikungunya virus infection in small infants. Eur J Pediatr 2010; 169:67-72.
60. Roth A, Mercier A, Lepers C, et al. Concurrent outbreaks of dengue, chikungunya and Zika virus infections-an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012-2014. Euro Surveill 2014; 19:.
61. Smith DW, Speers DJ, Mackenzie JS. The viruses of Australia and the risk to tourists. Travel Med Infect Dis 2011; 9:113-125.
62. Russell RC, Dwyer DE. Arboviruses associated with human disease in Australia. Microbes Infect 2000; 2:1693-1704.
63. Hueston L, Toi CS, Jeoffreys N, et al. Diagnosis of Barmah forest virus infection by a nested real-time SYBR green RT-PCR assay. PLoS One 2013; 8:e65197.
64. Dore A, Auld J. Barmah Forest viral exanthems. Aust J Dermatol 2004; 45:125-129.
65. Lott JP, Liu K, Landry M-L, et al. Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infection. J Am Acad Dermatol 2013; 69:736-741.
66. Centers for Disease Control. Notes from the field: Severe hand, foot, and mouth disease associated with coxsackievirus A6-Alabama, Connecticut, California, and Nevada, November 2011-February 2012. MMWR Morb Mortal Wkly Rep 2012; 61:213-214.
67. Halsey ES, Williams M, Laguna-Torres VA, et al. Occurrence and correlates of symptom persistence following acute dengue fever in Peru. Am J Trop Med Hyg 2014; 90:449-456.
68. Carod-Artal FJ,Wichmann O, Farrar J, Gascó n J. Neurological complications of dengue virus infection. Lancet Neurol 2013; 12:906-919.
69. Olkowski S, Forshey BM, Morrison AC, et al. Reduced risk of disease during postsecondary dengue virus infections. J Infect Dis 2013; 208:1026-1033.
70. Guilarde AO, Turchi MD Jr, J BS, et al. Dengue and dengue hemorrhagic fever among adults: Clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis 2008; 197:817-824.
71. Simmons CP, Farrar JJ, van Vinh CN, et al. Dengue N Engl J Med 2012; 366:1423-1432.
72. Grard G, Caron M, Mombo IM, et al. Zika virus in Gabon (central Africa)-2007: A new threat from Aedes albopictus? PLoS Negl Trop Dis 2014; 8:e2681.
73. Kutsuna S, Kato Y, Takasaki T, et al. Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014 [corrected]. Euro Surveill 2014; 19:.
74. Rossi SL, Ross TM, Evans JD. West Nile virus. Clin Lab Med 2010; 30:47-65.
75. Outhred AC, Kok J, Dwyer DE. Neuroviral Infections: General Principles and DNA Viruses. Singh SK, Ruzek D, editors. Boca Raton, FL: CRC Press; 2012.
76. Kuhn JH. Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies. Arch Virol Suppl 2008; 20:13-360.
77. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: Clinical observations in 103 patients. J Infect Dis 1999; 179 (s1):S1-S7.
78. Lamunu M, Lutwama JJ, Kamugisha J, et al. Containing a haemorrhagic fever epidemic: The Ebola experience in Uganda (October 2000-January 2001). Int J Infect Dis 2004; 8:27-37.
79. Team ROAWIS. Ebola haemorrhagic fever in Sudan, 1976. Bulletin of the World Health Organization. World Health Organiz 1978; 56:247.
80. Wyplosz B, Carlotti A, Escaut L, et al. Initial human herpesvirus-8 rash and multicentric Castleman disease. Clin Infect Dis 2008; 47:684-688.
81. Budavari JM, Grayson W. Papular follicular eruptions in human immunodeficiency virus-positive patients in South Africa. Int J Dermatol 2007; 46:706-710.
82. Stone JH, Murali MR. Case records of the Massachusetts General Hospital. Case 10-2013. A 30-year-old man with fever, myalgias, arthritis, and rash. N Engl J Med 2013; 368:1239-1245.
83. Al-Shukri I, Davidson E, Tan A, et al. Rash and arthralgia caused by hepatitis E. The Lancet 2013; 382:1856.
84. Albariño CG, Foltzer M, Towner JS, et al. Novel paramyxovirus associated with severe acute febrile disease, South Sudan and Uganda, 2012. Emerg Infect Dis 2014; 20:211-216.
85. Molina-Ruiz AM, Santonja C, Rü tten A, et al. Immunohistochemistry in the diagnosis of cutaneous viral infections-part I. Cutaneous viral infections by herpesviruses and papillomaviruses. Am J Dermatopathol 2015; 37:1-14.
86. Molina-Ruiz AM, Santonja C, Rü tten A, et al. Immunohistochemistry in the diagnosis of cutaneous viral infections-Part II: Cutaneous viral infections by parvoviruses, poxviruses, paramyxoviridae, picornaviridae, retroviruses and filoviruses. Am J Dermatopathol 2015; 37:93-106.